New Patent Could Be Worth $6 type A Share To Amgen Forbes Geoffrey Porges and his team of analysts At Sanford C. Bernstein took another look at the patent Amgen was issued last week on the top-selling drug Enbrel, in use to treat rheumatoid arthritis, psoriasis , and another immune diseases. ... Link To Article
No comments:
Post a Comment